138 related articles for article (PubMed ID: 8871001)
21. The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis.
van der Wall E; Schaake-Koning CC; van Zandwijk N; Baars JW; Schornagel JH; Richel DJ; Rutgers EJ; Borger JH; Beijnen JH; Rodenhuis S
Eur J Cancer; 1996 Aug; 32A(9):1490-7. PubMed ID: 8911107
[TBL] [Abstract][Full Text] [Related]
22. Impact of radiation therapy on acute toxicity in breast conservation therapy for early breast cancer.
Back M; Guerrieri M; Wratten C; Steigler A
Clin Oncol (R Coll Radiol); 2004 Feb; 16(1):12-6. PubMed ID: 14768750
[TBL] [Abstract][Full Text] [Related]
23. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy.
Markiewicz DA; Schultz DJ; Haas JA; Harris EE; Fox KR; Glick JH; Solin LJ
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):661-8. PubMed ID: 8690631
[TBL] [Abstract][Full Text] [Related]
24. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma.
Livi L; Saieva C; Borghesi S; Paoletti L; Meattini I; Rampini A; Petrucci A; Scoccianti S; Paiar F; Cataliotti L; Leonulli BG; Bianchi S; Biti GP
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):705-9. PubMed ID: 18191333
[TBL] [Abstract][Full Text] [Related]
25. [Adjuvant combined radiochemotherapy: a feasibility study of a new strategy in stages I and II].
Serin D; Aimard L; Kirscher S; Brewer Y; Félix-Faure C; Vincent P; Chauvet B; Reboul F
Bull Cancer; 1997 Mar; 84(3):247-53. PubMed ID: 9207869
[TBL] [Abstract][Full Text] [Related]
26. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel.
Taghian AG; Assaad SI; Niemierko A; Kuter I; Younger J; Schoenthaler R; Roche M; Powell SN
J Natl Cancer Inst; 2001 Dec; 93(23):1806-11. PubMed ID: 11734597
[TBL] [Abstract][Full Text] [Related]
27. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.
Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Breteau N; Body G; Azria D; Le Floch O; Calais G
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):324-32. PubMed ID: 16542788
[TBL] [Abstract][Full Text] [Related]
28. Accelerated partial breast irradiation using 3D conformal radiotherapy: toxicity and cosmetic outcome.
Gatti M; Ponzone R; Bresciani S; Panaia R; Kubatzki F; Maggiorotto F; Di Virgilio MR; Salatino A; Baiotto B; Montemurro F; Stasi M; Gabriele P
Breast; 2013 Dec; 22(6):1136-41. PubMed ID: 23958374
[TBL] [Abstract][Full Text] [Related]
29. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.
Burstein HJ; Bellon JR; Galper S; Lu HM; Kuter I; Taghian AG; Wong J; Gelman R; Bunnell CA; Parker LM; Garber JE; Winer EP; Harris JR; Powell SN
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):496-504. PubMed ID: 16243442
[TBL] [Abstract][Full Text] [Related]
30. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients.
Yu TK; Whitman GJ; Thames HD; Buzdar AU; Strom EA; Perkins GH; Schechter NR; McNeese MD; Kau SW; Thomas ES; Hortobagyi GN; Buchholz TA
J Natl Cancer Inst; 2004 Nov; 96(22):1676-81. PubMed ID: 15547180
[TBL] [Abstract][Full Text] [Related]
31. Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. a prospective, comparative, non-randomised study.
Fiets WE; van Helvoirt RP; Nortier JW; van der Tweel I; Struikmans H
Eur J Cancer; 2003 May; 39(8):1081-8. PubMed ID: 12736107
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.
Lee SW; Choi EK; Lee JS; Lee SD; Suh C; Kim SW; Kim WS; Ahn SD; Yi BY; Kim JH; Noh YJ; Kim SS; Koh Y; Kim DS; Kim WD
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):996-1004. PubMed ID: 12829135
[TBL] [Abstract][Full Text] [Related]
33. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group.
Johnstone DW; Byhardt RW; Ettinger D; Scott CB
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):365-9. PubMed ID: 12243809
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer--toxicity and dose modification: a Transtasman Radiation Oncology Group Multi-Institution study.
Denham JW; Hamilton CS; Christie D; O'Brien M; Bonaventura A; Stewart JF; Ackland SP; Lamb DS; Spry NA; Dady P
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):305-13. PubMed ID: 7836084
[TBL] [Abstract][Full Text] [Related]
35. Myelodysplastic syndrome as a complication of neo-adjuvant triple M chemotherapy and radiotherapy.
Partridge SE; Lowdell CP
Clin Oncol (R Coll Radiol); 1999; 11(3):187-9. PubMed ID: 10465474
[TBL] [Abstract][Full Text] [Related]
36. Chemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma.
Mulayim N; Foster Silver D; Schwartz PE; Higgins S
Gynecol Oncol; 2004 Jun; 93(3):659-66. PubMed ID: 15196861
[TBL] [Abstract][Full Text] [Related]
37. Symptomatic Radiation Pneumonitis After Accelerated Partial Breast Irradiation Using Three-dimensional Conformal Radiotherapy.
Shikama N; Kumazaki YU; Miyazawa K; Miyaura K; Kato S; Nakamura N; Kawamori J; Shimizuguchi T; Saito N; Saeki T
Anticancer Res; 2016 May; 36(5):2475-9. PubMed ID: 27127160
[TBL] [Abstract][Full Text] [Related]
38. A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.
Powles TJ; Jones AL; Judson IR; Hardy JR; Ashley SE
Br J Cancer; 1991 Aug; 64(2):406-10. PubMed ID: 1892775
[TBL] [Abstract][Full Text] [Related]
39. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?
Taghian AG; Assaad SI; Niemierko A; Floyd SR; Powell SN
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):386-91. PubMed ID: 15890579
[TBL] [Abstract][Full Text] [Related]
40. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer.
Pierce SM; Recht A; Lingos TI; Abner A; Vicini F; Silver B; Herzog A; Harris JR
Int J Radiat Oncol Biol Phys; 1992; 23(5):915-23. PubMed ID: 1639653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
